Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-11

Clinical Trial Update: Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial of imiquimod for breast cancer patients with chest wall recurrence or skin metastases has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod (imiquimod)

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer, Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2012-05-11